In critically ill patients with sepsis-induced immunosuppression, GM-CSF restores monocyte expression of HLA-DR (231) and improves neutrophils phagocytic capacity in patients with impaired neutrophil phagocytosis (232). The gene discussed is CSF2; the disease is Sepsis.